Narwhal Capital Management Decreases Stock Holdings in Procter & Gamble Company (The) $PG

Narwhal Capital Management decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 2.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 99,985 shares of the company’s stock after selling 2,014 shares during the period. Procter & Gamble makes up 1.3% of Narwhal Capital Management’s portfolio, making the stock its 19th largest holding. Narwhal Capital Management’s holdings in Procter & Gamble were worth $15,930,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of PG. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC grew its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares during the period. Quarry LP bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $33,000. Mizuho Securities Co. Ltd. grew its stake in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 170 shares during the period. Finally, RMG Wealth Management LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares in the company, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 490 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares in the company, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 in the last ninety days. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Stock Down 1.2%

NYSE PG opened at $150.67 on Thursday. The stock’s 50 day moving average is $155.26 and its 200 day moving average is $159.72. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The stock has a market cap of $352.64 billion, a PE ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the firm posted $1.40 EPS. Procter & Gamble’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. BNP Paribas Exane cut their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Barclays cut their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Finally, Wells Fargo & Company cut their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $172.58.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.